These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
336 related items for PubMed ID: 31078540
1. The Diagnostic Utility of Multifocal Electroretinography in Detecting Chloroquine and Hydroxychloroquine Retinal Toxicity. Tsang AC, Ahmadi S, Hamilton J, Gao J, Virgili G, Coupland SG, Gottlieb CC. Am J Ophthalmol; 2019 Oct; 206():132-139. PubMed ID: 31078540 [Abstract] [Full Text] [Related]
2. Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test. Tsang AC, Ahmadi Pirshahid S, Virgili G, Gottlieb CC, Hamilton J, Coupland SG. Ophthalmology; 2015 Jun; 122(6):1239-1251.e4. PubMed ID: 25824328 [Abstract] [Full Text] [Related]
3. Detection of early hydroxychloroquine retinal toxicity enhanced by ring ratio analysis of multifocal electroretinography. Lyons JS, Severns ML. Am J Ophthalmol; 2007 May; 143(5):801-809. PubMed ID: 17336914 [Abstract] [Full Text] [Related]
4. Comparison of different screening methods for chloroquine/hydroxychloroquine retinopathy: multifocal electroretinography, color vision, perimetry, ophthalmoscopy, and fluorescein angiography. Missner S, Kellner U. Graefes Arch Clin Exp Ophthalmol; 2012 Mar; 250(3):319-25. PubMed ID: 22215255 [Abstract] [Full Text] [Related]
5. Disparity between visual fields and optical coherence tomography in hydroxychloroquine retinopathy. Marmor MF, Melles RB. Ophthalmology; 2014 Jun; 121(6):1257-62. PubMed ID: 24439759 [Abstract] [Full Text] [Related]
6. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF, American Academy of Ophthalmology. Ophthalmology; 2011 Feb; 118(2):415-22. PubMed ID: 21292109 [Abstract] [Full Text] [Related]
7. Visual field and multifocal electroretinography and their correlations in patients on hydroxychloroquine therapy. Lai TY, Ngai JW, Chan WM, Lam DS. Doc Ophthalmol; 2006 May; 112(3):177-87. PubMed ID: 16804707 [Abstract] [Full Text] [Related]
8. A novel method for screening the multifocal electroretonogram in patients using hydroxychloroquine. Chang WH, Katz BJ, Warner JE, Vitale AT, Creel D, Digre KB. Retina; 2008 May; 28(10):1478-86. PubMed ID: 18997610 [Abstract] [Full Text] [Related]
9. Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine. Kellner U, Renner AB, Tillack H. Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3531-8. PubMed ID: 16877425 [Abstract] [Full Text] [Related]
10. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Michaelides M, Stover NB, Francis PJ, Weleber RG. Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626 [Abstract] [Full Text] [Related]
11. Subjective and objective screening tests for hydroxychloroquine toxicity. Cukras C, Huynh N, Vitale S, Wong WT, Ferris FL, Sieving PA. Ophthalmology; 2015 Feb; 122(2):356-66. PubMed ID: 25444344 [Abstract] [Full Text] [Related]
12. A novel 5-ring multifocal electroretinography stimulus for detecting hydroxychloroquine retinal toxicity. Tsang A, Kanda P, Gottlieb C, Virgili G, Kantungane L, Coupland S. Doc Ophthalmol; 2022 Apr; 144(2):117-124. PubMed ID: 34762206 [Abstract] [Full Text] [Related]
14. Impact of the revised american academy of ophthalmology guidelines regarding hydroxychloroquine screening on actual practice. Browning DJ. Am J Ophthalmol; 2013 Mar; 155(3):418-428.e1. PubMed ID: 23218706 [Abstract] [Full Text] [Related]
15. Rapid Onset of Retinal Toxicity From High-Dose Hydroxychloroquine Given for Cancer Therapy. Leung LS, Neal JW, Wakelee HA, Sequist LV, Marmor MF. Am J Ophthalmol; 2015 Oct; 160(4):799-805.e1. PubMed ID: 26189086 [Abstract] [Full Text] [Related]
16. Case Report: Hydroxychloroquine Retinopathy. Eldeeb M, Chan EW, Omar A. Optom Vis Sci; 2018 Jun; 95(6):545-549. PubMed ID: 29787487 [Abstract] [Full Text] [Related]
17. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF, American Academy of Ophthalmology. Ophthalmology; 2016 Jun; 123(6):1386-94. PubMed ID: 26992838 [Abstract] [Full Text] [Related]
18. Comparison between multifocal ERG and C-Scan SD-OCT ("en face" OCT) in patients with a suspicion of antimalarial retinal toxicity: preliminary results. Arndt C, Costantini M, Chiquet C, Afriat M, Berthemy S, Vasseur V, Ducasse A, Mauget-Faÿsse M. Doc Ophthalmol; 2018 Apr; 136(2):97-111. PubMed ID: 29536324 [Abstract] [Full Text] [Related]
19. A comparison of structural and functional changes in patients screened for hydroxychloroquine retinopathy. Greenstein VC, Amaro-Quireza L, Abraham ES, Ramachandran R, Tsang SH, Hood DC. Doc Ophthalmol; 2015 Feb; 130(1):13-23. PubMed ID: 25502494 [Abstract] [Full Text] [Related]
20. Quantitative assessment of the 103-hexagon multifocal electroretinogram in detection of hydroxychloroquine retinal toxicity. Adam MK, Covert DJ, Stepien KE, Han DP. Br J Ophthalmol; 2012 May; 96(5):723-9. PubMed ID: 22328813 [Abstract] [Full Text] [Related] Page: [Next] [New Search]